mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.062 |
0.8 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |